药物成型手册 1286条(本栏目收费,不能显示细节,电话13136136841)
physicochemical/biological properties 56,61,334,338 338
specifications 332,333 333
Food and Drug Administration (FDA) 1;dietary supplements 7,8 8
marketing authorization 33,34 34
food sensory analysis 141,142 142
forced degradation studies 317,359,360,450,454 454
forked PEGs (PEG-X2) 426 426
48-H release formulation 471,472 472
Fourier transform-infrared (FT-IR) spectroscopy 75,260,425 425
fragment-based screening (FBS) 4,5 5
Franz diffusion cell approach 230 230
deliquescence 250,251 251
De Materia Medica (book) 485 485
denaturation process 444,445 445
denileukin diftitox 411 411
design of experiments (DoE) approach 477 477
design qualification (DQ) 370,435 435
desorption phase,moisture content 267 267
development phases,drug discovery: candidate drug screening 10,11 11
candidate drug selection 11,12 12
lead finding/establishing directions 9,10 10
phase I clinical studies 12,13 13
phase II/III studies 13 13
postmarket surveillance 13,14 14
preclinical studies 12 12